Questionnaire-based assessment on knowledge, attitude and practice of fixed-dose combination in medical undergraduates of a tertiary care teaching hospital, Kanpur

Virendra Kushwaha; Pooja Agrawal; Alpana Sahu; Pushpendra Pushkar; Nasreen F. Khan; Harsh Vekaria

doi:10.18203/2319-2003.ijbcp20240377

Authors

Virendra Kushwaha Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Pooja Agrawal Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Alpana Sahu Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Pushpendra Pushkar Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Nasreen F. Khan Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India
Harsh Vekaria Department of Pharmacology, GSVM Medical College, Kanpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20240377

Keywords:

Fixed dose combination, Drug resistance, Pre-test, Post-test

Abstract

Background: Aim was to assess knowledge, attitude and practice of second-year medical undergraduates towards FDC.

Methods: A cross-sectional questionnaire-based study was conducted among second-year medical undergraduates of GSVM, medical college, Kanpur in the form of a pre-test, and after sensitizing the students about FDC, the same questionnaire was given as a post-test.

Results: A total of 251 students, 157 students participated in the pre-test and 140 participated in the post-test. The percentage of male students in pre and post-test were more (58% and 61.4%) compared to female students (42% and 38.6%). After conducting a post-test survey, there is a significant improvement in knowledge and attitude toward FDC.

Conclusions: The inclusion of FDC in the undergraduate curriculum is a good initiative by NMC but there is a need to conduct more CME, symposiums, and workshops in medical colleges to update the knowledge regarding FDC among medical undergraduates.

Metrics

Metrics Loading ...

References

Sreedhar D, Subramanian G, Udupa N. Combination drugs: are they rational? Curr Sci. 2006;91(4):406.

Auwal F, Dahiru MN, Abdu-Aguye SN. Availability and rationality of fixed dose combinations available in Kaduna, Nigeria. Pharm Pract (Granada). 2019;17(2):1470.

World Health Organization. The use of essential drugs. WHO Technical Report Series 825. Geneva: World Health Organization. 1992. Available at: www.medlineindia.com. Accessed on 15th August 2023.

Bangalore S, Kamalakkannan G, Parkar S, Franz HM. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-9.

Menditto E, Orlando Rosa G, Paola M, Umberto MM, Caitriona C et al. Patient-centric pharmaceutical drug product design-the impact on medication adherence. Pharmaceutics. 2020;12(1):E44.

Kastury N, Singh S, Ansari KU. An audit of prescription for rational use of fixed-dose drug combinations. Indian J Pharmacol. 1999;31:367 69.

Iftikha S, Sarwar MR. Potential disadvantages associated with treatment of active tuberculosis using fixed-dose combination: a review of literature. J Basic Clin Pharm. 2017;8:S131-6.

Amitava S. Indian market's fixation with fixed-dose combinations (Editorial.) Rational Drug Bull. 2002;12:1.

Guidelines on Fixed dose combination. Available at: http://www.medlineindia.com/acts/guidelines%20on%20fixed%20%dose%20combination. Accessed on 12 November, 2023.

Panda J, Tiwari P, Uppal R. Evaluation of rationality of some FDC: Focus on antihypertensive drugs. Indian J Pharm Sci. 2006;68:649 52.

Azmi T, Agarwal P, Kushwaha, Mohan S, Kumar A, Sharma H. Comparative analysis of efficacy and safety of fixed versus the free equivalent combination of 1% Brinzolamide and 0.5% Timolol in glaucoma patients: A prospective observational study. IJPR. 2021;13(2):1104-10.

Moulding T. Fixed-Dose Combinations of Ant tuberculous medications to prevent drug resistance. Ann Intern Med. 1995;122(12):951.

Hutchins V, Zhang B, Fleurence R, Krishnarajah G, Graham J. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin. 2011;27(6):1157-68.

825. Geneva: World Health Organization, 1992. 3. www.medlineindia.com. Guidelines on Fixed Dose Combinations. Cited on 28 Aug 2022. Available at: http://www.medlineindia.com/acts/guidelines%20on%20fixed%20dose%20combinations. Accessed on 12 November, 2023.

Kushwaha V, Agarwal P, Azmi T, Shukla V, Das A. Fixed dose combination -Rationale, use, Advantages, and disadvantages Brief Review. WJPR. 2022;11(3):628-38

Gautam CS, Saha L. Fixed dose drug combinations (FDCs): rational or irrational: a view point. Br J Clin Pharmacol. 2008;65(5):795-6.

Ravichandran A, Balamurugan J, Shankareswari, Sekar R. Knowledge, attitude and prescriptional practice about fixed dose combinations among medical practitioners in tertiary care hospital. Int J Basic Clin Pharmacol. 2017;6:1937-42.

Gupta R, Malhotra P, Malhotra A. Assessment of knowledge, attitude, and practices about prescribing fixed dose combinations among doctors - An observational study. Natl J Physiol Pharm Pharmacol. 2018;8(3):347-52

Vinnakota NR, Krishna V, Viswanath V, Ahmed Z, Shaik KS, Boppana NK. Assessment of knowledge, attitude, and practices on fixed dose combinations among postgraduate dental students. J Int Soc Prevent Communit Dent. 2016;6:S243-7

Goswami N, Gandhi A, Patel P, Dikshit R. An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctors. Perspect Clin Res. 2013;4(2):130-5.